| Azithromycin to reduce childhood mortality in sub-Saharan Africa JD Keenan, RL Bailey, SK West, AM Arzika, J Hart, J Weaver, K Kalua, ... New England Journal of Medicine 378 (17), 1583-1592, 2018 | 357 | 2018 |
| Effect of oral voriconazole on fungal keratitis in the mycotic ulcer treatment trial II (MUTT II): a randomized clinical trial NV Prajna, T Krishnan, R Rajaraman, S Patel, M Srinivasan, M Das, ... JAMA ophthalmology 134 (12), 1365-1372, 2016 | 167 | 2016 |
| Macrolide and nonmacrolide resistance with mass azithromycin distribution T Doan, L Worden, A Hinterwirth, AM Arzika, R Maliki, A Abdou, L Zhong, ... New England Journal of Medicine 383 (20), 1941-1950, 2020 | 155 | 2020 |
| Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review KS O'Brien, P Emerson, PJ Hooper, AL Reingold, EG Dennis, JD Keenan, ... The Lancet Infectious Diseases 19 (1), e14-e25, 2019 | 148 | 2019 |
| The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial M Srinivasan, J Mascarenhas, R Rajaraman, M Ravindran, P Lalitha, ... American journal of ophthalmology 157 (2), 327-333. e3, 2014 | 123 | 2014 |
| Longer-term assessment of azithromycin for reducing childhood mortality in Africa JD Keenan, AM Arzika, R Maliki, N Boubacar, S Elh Adamou, ... New England Journal of Medicine 380 (23), 2207-2214, 2019 | 83 | 2019 |
| In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial P Lalitha, CQ Sun, NV Prajna, R Karpagam, M Geetha, KS O'Brien, ... American journal of ophthalmology 157 (2), 318-326, 2014 | 75 | 2014 |
| Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis CQ Sun, P Lalitha, NV Prajna, R Karpagam, M Geetha, KS O'Brien, ... Ophthalmology 121 (8), 1495-1500. e1, 2014 | 71 | 2014 |
| Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED) A Sy, KS O’Brien, MP Liu, PA Cuddapah, NR Acharya, TM Lietman, ... Bmc Ophthalmology 15, 1-6, 2015 | 61 | 2015 |
| Adjunctive oral voriconazole treatment of Fusarium keratitis: a secondary analysis from the Mycotic Ulcer Treatment Trial II NV Prajna, T Krishnan, R Rajaraman, S Patel, R Shah, M Srinivasan, ... JAMA ophthalmology 135 (6), 520-525, 2017 | 51 | 2017 |
| Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster … JD Keenan, AM Arzika, R Maliki, SE Adamou, F Ibrahim, M Kiemago, ... The Lancet Global Health 8 (2), e288-e295, 2020 | 49 | 2020 |
| Traditional herbalists and cancer management in Kumasi, Ghana KS O’Brien, AS Soliman, K Annan, RN Lartey, B Awuah, SD Merajver Journal of Cancer Education 27, 573-579, 2012 | 46 | 2012 |
| Mass azithromycin distribution to prevent childhood mortality: a pooled analysis of cluster-randomized trials CE Oldenburg, AM Arzika, A Amza, T Gebre, K Kalua, Z Mrango, ... The American journal of tropical medicine and hygiene 100 (3), 691, 2019 | 37 | 2019 |
| Mass azithromycin distribution and community microbiome: a cluster-randomized trial T Doan, A Hinterwirth, AM Arzika, SY Cotter, KJ Ray, KS O’Brien, L Zhong, ... Open forum infectious diseases 5 (8), ofy182, 2018 | 35 | 2018 |
| Visual outcomes in treated bacterial keratitis: four years of prospective follow-up SM McClintic, NV Prajna, M Srinivasan, J Mascarenhas, P Lalitha, ... Investigative ophthalmology & visual science 55 (5), 2935-2940, 2014 | 35 | 2014 |
| Mycotic Ulcer Treatment Trial II Group. Effect of oral voriconazole on fungal keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): a randomized clinical trial NV Prajna, T Krishnan, R Rajaraman, S Patel, M Srinivasan, M Das, ... JAMA Ophthalmol 134 (12), 1365-1372, 2016 | 34 | 2016 |
| How can nutrition research better reflect the relationship between wasting and stunting in children? Learnings from the Wasting and Stunting project K Sadler, PT James, ZA Bhutta, A Briend, S Isanaka, A Mertens, M Myatt, ... The Journal of nutrition 152 (12), 2645-2651, 2022 | 33 | 2022 |
| Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial L Guglielmetti, E Ardizzoni, M Atger, E Baudin, E Berikova, M Bonnet, ... Trials 22, 1-15, 2021 | 31 | 2021 |
| Establishing effective registration systems in resource-limited settings: cancer registration in Kumasi, Ghana KS O’Brien, AS Soliman, B Awuah, E Jiggae, E Osei-Bonsu, S Quayson, ... Journal of registry management 40 (2), 70, 2013 | 31 | 2013 |
| Childhood mortality after mass distribution of azithromycin: a secondary analysis of the PRET cluster-randomized trial in Niger KS O’Brien, SY Cotter, A Amza, B Kadri, B Nassirou, NE Stoller, Z Zhou, ... The Pediatric infectious disease journal 37 (11), 1082-1086, 2018 | 29 | 2018 |
Catherine E. OldenburgAssociate Professor, University of California, San FranciscoVerified email at ucsf.edu
